0000000001009448

AUTHOR

Antonino Di Natale

showing 1 related works from this author

Plasma cortisol level in amyotrophic lateral sclerosis

2015

Background. Amyotrophic Lateral sclerosis (ALS) is associated with a significant distress, being linked to changes in hypothalamic-pituitary-adrenal axis activity. A loss of cortisol circadian rhythmicity in ALS patients was suggested, while more recently an increased plasma cortisol level in the disease has been reported. Objective. To assay the circadian plasma cortisol level in ALS and to study its relationship with the clinical phenotype and the rate of disease progression. Patients and methods. 135 ALS patients (Bulbar, 33; Spinal, 102; M/F = 1.73) and 110 controls (not affected by neurological or psychiatric disorders, free of drugs; M/F = 1.75) were recruited. Disease progression was…

Malemedicine.medical_specialtyNeurologyHydrocortisonemedicine.medical_treatmentCortisolInternal medicineALSFRS-RmedicineHumansCircadian rhythmAmyotrophic lateral sclerosisAgedHydrocortisoneMorningbusiness.industryAmyotrophic Lateral SclerosisBiomarkerMiddle Agedmedicine.diseaseCircadian RhythmSteroid hormoneEndocrinologyNeurologyDisease ProgressionBiomarker (medicine)FemaleNeurology (clinical)ALSbusinessBiomarkersmedicine.drugHormoneJournal of the Neurological Sciences
researchProduct